300 related articles for article (PubMed ID: 11255422)
1. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy and fatal ovarian cancer.
Rodriguez C; Calle EE; Coates RJ; Miracle-McMahill HL; Thun MJ; Heath CW
Am J Epidemiol; 1995 May; 141(9):828-35. PubMed ID: 7717359
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
4. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.
Willis DB; Calle EE; Miracle-McMahill HL; Heath CW
Cancer Causes Control; 1996 Jul; 7(4):449-57. PubMed ID: 8813433
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone replacement therapy and risk of ovarian cancer.
Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
7. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.
Rodriguez C; Calle EE; Fakhrabadi-Shokoohi D; Jacobs EJ; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):822-8. PubMed ID: 12223425
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and ovarian cancer.
Folsom AR; Anderson JP; Ross JA
Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy and ovarian cancer.
Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.
Calle EE; Miracle-McMahill HL; Thun MJ; Heath CW
J Natl Cancer Inst; 1995 Apr; 87(7):517-23. PubMed ID: 7707438
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
Hildebrand JS; Gapstur SM; Feigelson HS; Teras LR; Thun MJ; Patel AV
Int J Cancer; 2010 Dec; 127(12):2928-35. PubMed ID: 21351271
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of postmenopausal hormone use and ovarian cancer risk.
Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women.
Rodriguez C; Calle EE; Patel AV; Tatham LM; Jacobs EJ; Thun MJ
Am J Epidemiol; 2001 Jan; 153(2):145-52. PubMed ID: 11159159
[TBL] [Abstract][Full Text] [Related]
15. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
16. Back problems among postmenopausal women taking estrogen replacement therapy: the study of osteoporotic fractures.
Musgrave DS; Vogt MT; Nevitt MC; Cauley JA
Spine (Phila Pa 1976); 2001 Jul; 26(14):1606-12. PubMed ID: 11462095
[TBL] [Abstract][Full Text] [Related]
17. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.
Banks E; Beral V; Reeves G; Balkwill A; Barnes I;
JAMA; 2004 May; 291(18):2212-20. PubMed ID: 15138243
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone use and cholecystectomy in a large prospective study.
Grodstein F; Colditz GA; Stampfer MJ
Obstet Gynecol; 1994 Jan; 83(1):5-11. PubMed ID: 8272307
[TBL] [Abstract][Full Text] [Related]
19. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
